Impact of immunotherapy on the risk of thromboembolic disease in patients with melanoma

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorFernandez Garay, D.
dc.contributor.authorBlaya Boluda, N.
dc.contributor.authorOrtega Moran, L.
dc.contributor.authorBenoit-Perejon, J. Z.
dc.contributor.authorJimenez Colomo, L.
dc.contributor.authorLobo de Mena, M.
dc.contributor.authorQuintanar Verduguez, T.
dc.contributor.authorRuperez Blanco, A. B.
dc.contributor.authorMartin Fernandez de Soignie, A. M.
dc.contributor.authorRubio Perez, J.
dc.contributor.authorFont Puig, C.
dc.contributor.authorObispo Portero, B.
dc.contributor.authorGuirao Rubio, C.
dc.contributor.authorBosque Moreno, J.
dc.contributor.authorRosa Garrido, M. C.
dc.contributor.authorMunoz Martin, A.
dc.contributor.authorSanchez Canovas, M.
dc.contributor.authoraffiliation[Fernandez Garay, D.] Hosp Univ Jaen, Dept Med Oncol, Jaen, Spain
dc.contributor.authoraffiliation[Benoit-Perejon, J. Z.] Hosp Univ Jaen, Dept Med Oncol, Jaen, Spain
dc.contributor.authoraffiliation[Rosa Garrido, M. C.] Hosp Univ Jaen, Dept Med Oncol, Jaen, Spain
dc.contributor.authoraffiliation[Blaya Boluda, N.] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
dc.contributor.authoraffiliation[Sanchez Canovas, M.] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
dc.contributor.authoraffiliation[Ortega Moran, L.] Hosp Gen Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Madrid, Spain
dc.contributor.authoraffiliation[Munoz Martin, A.] Hosp Gen Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Madrid, Spain
dc.contributor.authoraffiliation[Jimenez Colomo, L.] Inst Catalan Oncol Hosp, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Lobo de Mena, M.] Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Quintanar Verduguez, T.] Hosp Gen Univ Elche, Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Guirao Rubio, C.] Hosp Gen Univ Elche, Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Bosque Moreno, J.] Hosp Gen Univ Elche, Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Ruperez Blanco, A. B.] Complejo Hosp Toledo, Dept Med Oncol, Toledo, Spain
dc.contributor.authoraffiliation[Martin Fernandez de Soignie, A. M.] Hosp Univ Fuenlabrada, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Rubio Perez, J.] Fdn Jimenez Diaz, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Guirao Rubio, C.] Hosp Clin Barcelona, Internal Med, Barcelona, Spain
dc.contributor.authoraffiliation[Obispo Portero, B.] Hosp Univ Infanta Leonor, Dept Med Oncol, Madrid, Spain
dc.date.accessioned2025-01-07T14:40:29Z
dc.date.available2025-01-07T14:40:29Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1660
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1660
dc.identifier.urihttps://hdl.handle.net/10668/26577
dc.identifier.wosID700527703233
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Jaén
dc.page.numberS1181-S1181
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleImpact of immunotherapy on the risk of thromboembolic disease in patients with melanoma
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario de Jaén

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía